A systematic review comparing allogeneic hematopoietic stem cell transplant to gene therapy in sickle cell disease
Lianne E. Rotin, Kevin H.M. Kuo(University Health Network), Rajat Kumar(University Health Network), Auro Viswabandya(Princess Margaret Cancer Centre), Christopher J. Patriquin(University Health Network)
Cited by 15
Related Papers
International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts
|Blood|2015|1.2k
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia
|New England Journal of Medicine|2020|320
Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study
|Blood|2018|165
Safety and Efficacy of Mitapivat in Pyruvate Kinase Deficiency
|New England Journal of Medicine|2019|162